Article Figures & Data
Figures
- Figure 1.
Dyspnea Relief (VAS AUC).
AUC=area under the curve; VAS=visual analog scale.
- Figure 2.
Cardiovascular Death Through Day 180.
CV=cardiovascular; ITT=intention-to-treat; KM=Kaplan-Meier; NNT=number needed to treat.
- Figure 3.
All-Cause Death Through Day 180.
KM=Kaplan-Meier; ITT=intention-to-treat; NNT=number needed to treat.
Figures 1 through 3 reprinted from The Lancet [Epub ahead of print Nov. 7, 2012], Teerlink JR et al. Serelaxin, Recombinant Human Relaxin-2, for Treatment of Acute Heart Failure (RELAX-AHF): A Randomised, Placebo-Controlled Trial.
Copyright 2012, with permission from Elsevier.
Tools
Serelaxin as a Novel Treatment for Acute Heart Failure: Results of the RELAX-AHF Trial
Permalink:
Table of contents
Cited By...
- No citing articles found.